European Archives - Page 898 of 1020 - European Medical Journal

EMJ

MedDay appoints Catherine Moukheibir as Chairman of its Board of Directors

Paris, France, 27 April 2016 – MedDay, a biotechnology company focused on the treatment of nervous system disorders, today announces the appointment of…

EMJ

Celyad Receives Certification for C-Cure® Non-Clinical Data from the European Medicines Agency (EMA)

C-Cure® (C3BS-CQR-1) is a cardiovascular lineage-committed cell therapy product being developed for the treatment of ischemic heart failure

EMJ

Introducing EMJ Urology 4.1

United Kingdom, April 21, 2016: This edition of the EMJ Urology eJournal, as in previous editions, is full of the latest news, reviews, interviews, and…

Prevention and Management of Biopsy Complications

Prostate biopsy is currently an essential procedure for prostate cancer diagnosis and the transrectal approach is most commonly used by European…

Review of the 31st Annual European Association of Urology Congress 2016

Being home to more than 200 biotechnology companies, and having once been voted the world’s most liveable city, Munich, Germany, was a perfect host for…

EMJ Urology 4.1 2016

This edition of the EMJ Urology eJournal, as in previous editions, is full of the latest news, reviews, interviews, and peer-reviewed articles.

High Power (200W) Thulium Laser Vaporisation of the Prostate with the Oyster Technique: Initial Experience and Early Postoperative Outcomes

Laser treatment of bladder outlet obstruction related to benign hyperplasia has gained wide acceptance during the last decade. The thulium:yttrium…

Managing Patients with Non-Muscle Invasive Bladder Cancer: Old Disease, New Ideas

Prof Per-Uno Malmström opened this symposium on non-muscle invasive bladder cancer (NMIBC) by describing the medical and economic burden caused by the…

Robotic Laparoendoscopic Single-Site Radical Prostatectomy: Ideal Phase I

Laparoendoscopic single-site surgery (LESS) represents any minimally invasive intra-abdominal surgical procedure performed through a single incision…

Editor’s Pick: PSMA-Specific Ligands in Prostate Cancer Diagnosis and Therapy

Prostate-specific membrane antigen (PSMA) is the most extensively studied biomarker and antigen of prostate cancer. It is overexpressed in almost all…